SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

Do Corticosteroids Really Raise Gestational Diabetes Risk?

Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.

From Taboo to Test: Can Menstrual Blood Aid Diagnosis?

Emerging research suggests that menstrual blood may provide valuable diagnostic and biological insights, with potential applications in cancer screening and endometriosis detection.

No Increased Retinopathy Risk Seen With Tirzepatide

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide.

Petrelintide Tolerability Could Improve on GLP-1 Challenges

The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows.

CGM Monitoring Benefits Extend to Non-Insulin-Using T2D

Patients with type 2 diabetes not taking insulin who use continuous glucose monitoring show significant reductions in A1c.

Obesity Meds Improve Patients' Perceived Physical Function

Obesity management medications improve patients' perceived physical function and have a 'modest' impact on an objective functional measure.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.

Emerging research suggests that menstrual blood may provide valuable diagnostic and biological insights, with potential applications in cancer screening and endometriosis detection.

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide.

The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows.

Patients with type 2 diabetes not taking insulin who use continuous glucose monitoring show significant reductions in A1c.

Obesity management medications improve patients' perceived physical function and have a 'modest' impact on an objective functional measure.

News All Time

Gestational GLP-1s Tied to Adverse Obstetric Outcomes

Underlying diabetes and discontinuation rebound in mothers with overweight are likely responsible rather than the drug itself.

Eating Out Exacerbating the Global Obesity Epidemic

Eating out instead of preparing food at home is exacerbating the global obesity epidemic, with half of adults worldwide eating out at least once a week.

Fezolinetant Linked to Enzyme Elevations

Fezolinetant is associated with a hepatic adverse event reporting signal characterized primarily by transaminase elevations rather than clinically overt liver injury.

GLP-1 Apps: Helpful Companions or False Sense of Security?

GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not accessible to most patients.

Study Sheds Light on Burden of Rare Bone Disease in France

Fibrous dysplasia or McCune-Albright syndrome affects approximately 5 per 1,000,000 hospitalised patients in France, with higher rates observed among children and women.

Surgery or Meds for Weight Regain After Sleeve Gastrectomy?

A retrospective study finds that conversion surgery after sleeve gastrectomy produces greater long-term weight loss than obesity medications for recurrent weight gain.

Modest Protein Restriction Tied to Better Outcomes in CKD

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

Inhaled Insulin Okayed for Kids With Diabetes Aged 6+ Years

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

The Latest in GLP-1-Based Therapy to be Featured at ADA

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

Processed Meat May Raise Gastric and Oesophageal Cancer Risk

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Continuous Glucose Monitoring: Is It Time to Expand Use?

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-Restricted Eating Reshapes Gut Flora, Aids Weight Loss

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

Tirzepatide Raises Thyroid Risk in Certain At-Risk Patients

Patients with end-stage renal disease or preexisting thyroid disease are more likely to experience either a new thyroid problem or a worsening of their thyroid disease while on tirzepatide.

Is It Time to Talk to Patients About Bowel Hygiene?

Advising patients about bowel hygiene is on the rise as understanding grows about the multifaceted nature of GI disorders.

France Becomes First EU Country to Reimburse Anti-obesity Drugs, Minister Says

France will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a ⁠first for a European Union country, Health Minister Stephanie...

PFAS Linked to Lower Bone Density in Youth

Data from the long-running HOME study links higher exposure to certain polyfluoroalkyl substances ‘forever chemicals’ with lower bone mineral density in children and adolescents.